Filtros de búsqueda

Lista de obras de Kent E Kester

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

artículo científico publicado en 2004

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium

artículo científico publicado en 2019

Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria.

artículo científico publicado en 2006

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

artículo científico publicado en 2003

Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen

artículo científico publicado en 2003

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

artículo científico publicado en 2003

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.

artículo científico publicado en 2009

Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine.

artículo científico publicado en 2010

Immunization with the RTS,S/AS malaria vaccine induces IFN-γ+CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge ⬇️

artículo científico publicado el 5 de octubre de 2011

Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria

artículo científico publicado en 2002

Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine ⬇️

artículo científico publicado el 1 de octubre de 1998

Nodular Cutaneous Microsporidiosis in a Patient with AIDS and Successful Treatment with Long-Term Oral Clindamycin Therapy

artículo científico publicado el 1 de junio de 1998

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

artículo científico publicado en 2005

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

artículo científico publicado en 2009

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine

artículo científico publicado en 2005

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

artículo científico publicado en 2009

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children

artículo científico publicado en 2005

The promise of mRNA vaccines: a biotech and industrial perspective

artículo científico publicado en 2020

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda